Menu
Back to Journals » Journal of Asthma and Allergy » Targeted Personalized Biologic Therapies: Changing the Game in Asthma Treatment
SJR OA
CiteScore
Impact Factor
ISSN: 1178-6965
- View all (934)
- Volume 18, 2025 (83)
- Volume 17, 2024 (117)
- Volume 16, 2023 (125)
- Volume 15, 2022 (151)
- Volume 14, 2021 (149)
- Volume 13, 2020 (77)
- Volume 12, 2019 (37)
- Volume 11, 2018 (31)
- Volume 10, 2017 (36)
- Volume 9, 2016 (25)
- Volume 8, 2015 (14)
- Volume 7, 2014 (14)
- Volume 6, 2013 (16)
- Volume 5, 2012 (10)
- Volume 4, 2011 (11)
- Volume 3, 2010 (20)
- Volume 2, 2009 (12)
- Volume 1, 2008 (6)
Journal Articles:
- Atopic Dermatitis and Other Atopic Comorbidities (5)
- Wheezing in Preschool Children: From Origins to Outcomes (1)
- From Guts to Lungs: Understanding Microbiome Dynamics in Respiratory Health (1)
- Artificial Intelligence and Machine Learning to Aid the Management of Allergic Respiratory Diseases (1)
- Anaphylaxis: Diagnosis and Treatment (5)
Targeted Personalized Biologic Therapies: Changing the Game in Asthma Treatment
Typical front-line treatments of asthma include corticosteroids (which cause immunosuppression with long-term use) and bronchodilators (such as albuterol inhalers). While biologic therapy is relatively new in asthma treatment, Global Initiative For Asthma (GINA) guidelines include biologics as therapeutic options. There are several biologics currently available and in development for the treatment of asthma.